Antibody development and disease severity of COVID-19 in non-immunised patients with rheumatic immune-mediated inflammatory diseases: data from a prospective cohort study
Laura Boekel, Femke Hooijberg, Erik H Vogelzang, Yaëlle R Besten, Maureen Leeuw, Sadaf Atiqi, Ronald F van Vollenhoven, Carla A Wijbrandts, Martijn Gerritsen, C Krieckaert, Bas Dijkshoorn, Siham Bakhlakh, Juliette J Crooijmans, Alexandre Voskuyl, Irene E van der Horst-Bruinsma, Willem Lems, Taco W Kuijpers, S Marieke van Ham, Luuk Wieske, Filip Eftimov, Laura Y Kummer, PJ Koos van Dam, Eileen W Stalman, Maurice Steenhuis, Sofie Keijzer, Olvi Cristianawati, Jim Keijser, Floris C Loeff, Sander W Tas, Michael T Nurmohamed, Maarten Boers, Theo Rispens, Gertjan Wolbink
RMD Open Apr 2022, 8 (1) e002035; DOI: 10.1136/rmdopen-2021-002035